Skip to main content
PNTGThe Pennant Group, Inc.Sell5.2·$41.13+0.12%
PNTG · Concentration risk · 10-K extracted

The Pennant Group (PNTG) concentration risks

Updated

The most significant concentration The Pennant Group discloses is Medicare (hospice services) at 87%, classified HIGH by disclosed size. Below: the full set from the latest 10-K — verbatim quotes, filing references, and a synthesis of what these exposures mean together.

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Source: The Pennant Group’s SEC Form 10-K filed view the filing on SEC EDGAR ↗

At a glance

Disclosed-size breakdown · 3 disclosed concentrations

HIGH2
MEDIUM1
LOW0
Disclosed concentrations

Each card carries a disclosed-size chip (HIGH / MEDIUM / LOW — how large the exposure is as a share of revenue, not how dangerous it is) and a nature tag: Built-in(the company’s own model, geography, or products) or Outside party (an external customer, supplier, or distributor it relies on).

HIGHBuilt-in & outside partyRegulatory
87%

Medicare (hospice services)

10-K Item 1: 'Medicare| | 43.8 | %| | 87.0 | %| | — | %| | 48.4 | %'
SEC 10-K · filed Feb 2026
HIGHBuilt-in & outside partyRegulatory
61.5%

government payors (Medicare and Medicaid)

10-K Item 1A: 'For the year ended December 31, 2025, 61.5% of our revenue was provided by government payors that reimburse us at predetermined rates, which is typical for our business.'
SEC 10-K · filed Feb 2026
MEDIUMBuilt-in & outside partyRegulatory
48.4%

Medicare

10-K Item 1A: 'We derived 48.4% of our revenue from the Medicare program for the year ended December 31, 2025, which is typical for our business.'
SEC 10-K · filed Feb 2026
TrendMatrix Research · concentration synthesis

What these concentrations mean together

updated 2026-07-26

Pennant Group's disclosed concentration is almost entirely a single-payor story. Government payors — Medicare and Medicaid combined — accounted for 61.5% of revenue for the year ended December 31, 2025, a high-share exposure. Medicare alone contributed 48.4% of revenue, a medium-share exposure, and within the hospice services line specifically, Medicare reimbursement reached 87.0%, a high-share concentration. All three exposures carry a mixed character: they blend policy-set reimbursement dynamics with elements of dependency, rather than sitting cleanly on one side or the other. That distinction matters for how the verdict could move — a rate cut or program-eligibility change would compress margins company-wide rather than through the loss of one client. The hospice segment's high-share Medicare dependence at 87.0% is the most consequential single line, since it ties a large slice of segment cash flow to one program's policy decisions, while the blended 61.5% government-payor share confirms the exposure runs across the business, not just hospice. Given the predictability of government reimbursement schedules relative to a commercial counterparty default, this reads as well-disclosed, policy-linked risk rather than an acute, idiosyncratic threat.

For the engine’s reasoning on PNTG’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.

Industry peers · Medical Care Facilities

Peer concentration profile

SymbolNameHIGHMEDIUMLOWTotal
PNTGThe Pennant Group, Inc.2103
ACHCAcadia Healthcare Company, Inc.1102
ADUSAddus HomeCare Corporation0246
ARDTArdent Health, Inc.0202
AMNAMN Healthcare Services Inc0011
AGLagilon health, inc.0000

Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.

Concentration disclosures are extracted verbatim from SEC 10-K filings; the disclosed-size classification and the synthesis above are engine-derived. Size reflects how large each exposure is against fixed share thresholds (HIGH >50%, MEDIUM 25–50%, LOW <25% or an explicit diversification statement), not a judgment of how dangerous it is, and is not a buy/sell rating, a price target, or a view on the stock. Not a complete list of risk factors — see the full filing.

Home Stocks PNTG Concentration risk